Publications

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors: H Farmer, N McCabe, CJ Lord, ANJ Tutt, DA Johnson, TB Richardson, M Santaro...

E-pub date: 14 Apr 2005

Journal name: Nature

Purified Argonaute2 and an siRNA form recombinant human RISC.

Authors: FV Rivas, NH Tolia, J-J Song, JP Aragon, J Liu, GJ Hannon, L Joshua-Tor

E-pub date: 1 Apr 2005

Journal name: Nat Struct Mol Biol

Scanning the Human Genome for Novel Therapeutic Targets for Breast Cancer

Authors: GJ Hannon

E-pub date: 1 Apr 2005

Journal name:

Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.

Authors: J Falck, J Coates, SP Jackson

E-pub date: 31 Mar 2005

Journal name: Nature

Gene regulation at the single-cell level.

Authors: N Rosenfeld, JW Young, U Alon, PS Swain, MB Elowitz

E-pub date: 25 Mar 2005

Journal name: Science

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Authors: TM Tekautz, CE Fuller, S Blaney, M Fouladi, A Broniscer, TE Merchant, M Kra...

E-pub date: 1 Mar 2005

Journal name: J Clin Oncol

Synthetic shRNAs as potent RNAi triggers.

Authors: D Siolas, C Lerner, J Burchard, W Ge, PS Linsley, PJ Paddison, GJ Hannon, M...

E-pub date: 1 Feb 2005

Journal name: Nat Biotechnol

Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.

Authors: A Mawson, A Lai, JS Carroll, CM Sergio, CJ Mitchell, B Sarcevic

E-pub date: 14 Jan 2005

Journal name: Mol Cell Endocrinol

Filters

Research Groups

Core Facilities

Start date

End date

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Purified Argonaute2 and an siRNA form recombinant human RISC.

Scanning the Human Genome for Novel Therapeutic Targets for Breast Cancer

Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.

Gene regulation at the single-cell level.

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Synthetic shRNAs as potent RNAi triggers.

Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Purified Argonaute2 and an siRNA form recombinant human RISC.

Scanning the Human Genome for Novel Therapeutic Targets for Breast Cancer

Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.

Gene regulation at the single-cell level.

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.

Synthetic shRNAs as potent RNAi triggers.

Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.